Zobrazeno 1 - 10
of 71
pro vyhledávání: '"M I, Ross"'
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-5 (2020)
Abstract Background Brain metastases from prostate cancer are rare and usually only occur in the context of widespread systemic disease. This is the first case report of a solitary brain oligometastasis, in a neurologically intact prostate cancer pat
Externí odkaz:
https://doaj.org/article/882fa02ebf3a4cbeb6fb07d4d5267342
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-1 (2020)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/a1bb284ea27f49f9adf9a6a28be27348
Autor:
R, Dummer, D E, Gyorki, J, Hyngstrom, A C, Berger, R, Conry, L, Demidov, A, Sharma, S A, Treichel, H, Radcliffe, K S, Gorski, A, Anderson, E, Chan, M, Faries, M I, Ross
Publikováno v:
Nature medicine. 27(10)
Talimogene laherparepvec (T-VEC) is a herpes simplex virus type 1-based intralesional oncolytic immunotherapy approved for the treatment of unresectable melanoma. The present, ongoing study aimed to estimate the treatment effect of neoadjuvant T-VEC
Autor:
Edward Chan, Lev V. Demidov, David E. Gyorki, Mark B. Faries, Hoi-Shen Radcliffe, John R. Hyngstrom, Robert M. Conry, M. I. Ross, Reinhard Dummer, Adam C. Berger
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Neoadjuvant immunotherapies and targeted therapies for advanced melanoma are an active area of investigation. This is the first clinical trial of an approved oncolytic viral immunotherapy as a neoadjuvant treatment in advanced melanoma and
Autor:
John M. Kirkwood, Keith T. Flaherty, John F. Thompson, Jeffrey E. Gershenwald, Mark B. Faries, Charles M. Balch, Grant A. McArthur, Richard A. Scolyer, Lauren E. Haydu, Alexander J. Lazar, M. I. Ross, Kenneth R. Hess, Vernon K. Sondak, Alexander M.M. Eggermont, Georgina V. Long
Publikováno v:
CA: A Cancer Journal for Clinicians. 67:472-492
Answer questions and earn CME/CNE To update the melanoma staging system of the American Joint Committee on Cancer (AJCC) a large database was assembled comprising >46,000 patients from 10 centers worldwide with stages I, II, and III melanoma diagnose
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-1 (2020)
An amendment to this paper has been published and can be accessed via the original article.
Autor:
Carlos A. Torres-Cabala, Jeffrey E. Gershenwald, Jason Roszik, Vruti Patel, Wen-Jen Hwu, Anthony Lucci, M. I. Ross, Arely Wahl, Orenthial J. Fulbright, Yuzhong Jeff Meng, Christopher Toth, Tatiana Karpinets, Cara Haymaker, Chantell M. Farinas, Sapna Pradyuman Patel, Adi Diab, Caitlin Creasy, Patrick Hwu, Renjith Ramachandran, Jeffrey E. Lee, Isabella C. Glitza, Ankit Bhatta, Destiny Joy Carpio, Rodabe N. Amaria, Esteban Flores, Suzanne Cain, Michael K. Wong, Laszlo Radvanyi, Rameen Beroukhim, Portia G. Velasquez, Hussein Abdul-Hassan Tawbi, Chantale Bernatchez, Carol Vaughn, Shawne T. Thorsen, Marie Andrée Forget, Michael A. Davies, Young Uk Kim, Seth Wardell, Janice N. Cormier, Scott E. Woodman, Jennifer A. Wargo, Rahmatu Mansaray, Richard E. Royal, Rene J. Tavera, Audrey M. Gonzalez, Kenneth R. Hess, Donastas Sakellariou-Thompson
Purpose: Adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) has consistently demonstrated clinical efficacy in metastatic melanoma. Recent widespread use of checkpoint blockade has shifted the treatment landscape, raising question
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fd2241bcc6c3505a54b6f6cfb5977d7
https://europepmc.org/articles/PMC6139043/
https://europepmc.org/articles/PMC6139043/
Publikováno v:
Cancer. 120:1361-1368
BACKGROUND In the current study, the authors sought to evaluate outcomes, specifically with respect to adjuvant radiotherapy (RT), for patients with desmoplastic melanoma. METHODS The records of 130 consecutive patients who presented between 1985 and
Autor:
Funda Meric-Bernstam, Gildy Babiera, Min Yi, K. K. Hunt, Anthony Lucci, CL Thomas, H. M. Kuerer, M. I. Ross
Publikováno v:
Cancer Research. 70:P4-10
Purpose To determine the risk of ipsilateral breast events (IBE) in patients with ductal carcinoma in situ (DCIS) treated with local excision. Patients and Methods We retrospectively identified 692 patients who had undergone local excision from 1968
Autor:
Eric Lentsch, Sandra L. Wong, Celia Chao, R. Dirk Noyes, Michael J. Edwards, M. I. Ross, Kelly M. McMasters, Wayne K. Stadelmann, Douglas S. Reintgen
Publikováno v:
Annals of Surgical Oncology. 10:21-26
Sentinel lymph node (SLN) biopsy for head and neck (HN) melanomas may be more technically challenging compared with other locations because of complex lymphatic drainage patterns. This analysis was performed to compare the results of SLN biopsy for H